Sponsor or institution
Clinical trials and research at Qurient Co., Ltd.
As of November 12, 2026, Find a Trial lists 2 clinical trials run by Qurient Co., Ltd. that are recruiting, at sites in 3 countries (most in South Korea (1), United States (1), Spain (1)). By phase: Phase 1/2 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 3Countries
All recruiting trials (2)
-
Adrixetinib (Q702) for adults with active chronic graft-versus-host disease.
This trial will test whether the oral drug Adrixetinib (Q702) is safe and helps adults with moderate or severe active chronic graft-versus-host disease who have not responded to standard treatments.
-
New treatment for advanced solid tumors using Q901 and pembrolizumab
This study is testing a new drug called Q901, alone or with pembrolizumab, to see if it can safely help people with advanced solid tumors.
Quick answers
How many clinical trials run by Qurient Co., Ltd. are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in South Korea (1 trial), United States (1 trial), Spain (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.